Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.
Simonitsch-Klupp I, Hauser I, Ott G, Drach J, Ackermann J, Kaufmann J, Weltermann A, Greinix HT, Skrabs C, Dittrich C, Lutz D, Pötter R, Mannhalter C, Lechner K, Chott A, Jaeger U. Simonitsch-Klupp I, et al. Among authors: jaeger u. Leukemia. 2004 Jan;18(1):146-55. doi: 10.1038/sj.leu.2403206. Leukemia. 2004. PMID: 14603341
Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia.
Mitterbauer M, Fritzer-Szekeres M, Mitterbauer G, Simonitsch I, Knöbl P, Rintelen C, Schwarzinger I, Haas OA, Silberbauer K, Frey K, Bibus B, Pabinger I, Radaszkiewicz T, Lechner K, Jaeger U. Mitterbauer M, et al. Among authors: jaeger u. Ann Hematol. 1996 Oct;73(4):189-93. doi: 10.1007/s002770050226. Ann Hematol. 1996. PMID: 8890708
Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.
Geissler K, Koller E, Hubmann E, Niederwieser D, Hinterberger W, Geissler D, Kyrle P, Knöbl P, Pabinger I, Thalhammer R, Schwarzinger I, Mannhalter C, Jaeger U, Heinz R, Linkesch W, Lechner K. Geissler K, et al. Among authors: jaeger u. Blood. 1997 Jul 15;90(2):590-6. Blood. 1997. PMID: 9226158 Free article. Clinical Trial.
Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.
Laczika K, Novak M, Hilgarth B, Mitterbauer M, Mitterbauer G, Scheidel-Petrovic A, Scholten C, Thalhammer-Scherrer R, Brugger S, Keil F, Schwarzinger I, Haas OA, Lechner K, Jaeger U. Laczika K, et al. Among authors: jaeger u. J Clin Oncol. 1998 Apr;16(4):1519-25. doi: 10.1200/JCO.1998.16.4.1519. J Clin Oncol. 1998. PMID: 9552061
240 results